Literature DB >> 7041656

Correlative microscopy and tissue culture of congenital hereditary endothelial dystrophy.

G A Stainer, P H Akers, P S Binder, E Y Zavala.   

Abstract

A 4 1/2-year-old boy with congenital hereditary endothelial dystrophy underwent successful bilateral penetrating keratoplasties. Visual acuity in both eyes was restored to 6/18 (20/60). Correlative microscopic analysis of the corneal button obtained from the first transplant showed an irregular epithelium, a continuously thickened Bowman's layer, fragmentation and homogenization of the anterior stromal lamellae, a mildly enlarged stromal fibril diameter, abnormal collagen layers posterior to Descemet's membrane, atrophic paracentral corneal endothelium, and absent central endothelium. The endothelial cells from the second corneal button were placed in tissue culture and failed to demonstrate any growth characteristics of differentiation into normal appearing cells after 14 days. We concluded that the endothelial cells in congenital hereditary endothelial dystrophy are functionally and morphologically abnormal. Early penetrating keratoplasty can be successful in such cases.

Entities:  

Mesh:

Year:  1982        PMID: 7041656     DOI: 10.1016/0002-9394(82)90134-9

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  3 in total

1.  Immuno-electron labelling of matrix components in congenital hereditary endothelial dystrophy.

Authors:  W Sekundo; G E Marshall; W R Lee; C M Kirkness
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1994-06       Impact factor: 3.117

2.  ROCK inhibitor enhances adhesion and wound healing of human corneal endothelial cells.

Authors:  Aurélien Pipparelli; Yvan Arsenijevic; Gilles Thuret; Philippe Gain; Michael Nicolas; François Majo
Journal:  PLoS One       Date:  2013-04-23       Impact factor: 3.240

3.  Corneal endothelial regeneration in human eyes using endothelium-free grafts.

Authors:  Lu-Yi Ying; Wen-Ya Qiu; Bing-Hong Wang; Ping Zhou; Bei Zhang; Yu-Feng Yao
Journal:  BMC Ophthalmol       Date:  2022-01-21       Impact factor: 2.209

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.